指南与共识外周血管介入DSA

优化静脉支架置入:改善下肢深静脉血栓管理的共识建议

Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis.
指南 / 共识 · Semin Thromb Hemost · 2024-05-11

该共识由20名内科、血管外科及介入放射学专家通过德尔菲法(2023年6月至7月)制定,围绕支架使用指征、支架选择与放置、并发症监测与预防三个主题共31条建议;其中23条(74.2%)达成共识,共识定义为主要参与者三分之二同意。共识集中于特定急性深静脉血栓情境下的支架放置及关键支架特性,但在预防移位的支架长度和基于髂腔分叉形态的支架特性上存在分歧;对短暂性重大危险因素所致深静脉血栓是否需超过3个月抗凝或支架置入后是否加用阿司匹林未达成共识。

要点

  • 共识涵盖支架使用指征、支架选择与放置、并发症监测与预防三个主题,共31条建议。
  • 31条建议中23条(74.2%)达成共识,共识定义为三分之二参与者同意。
  • 对短暂性重大危险因素所致深静脉血栓是否需超过3个月抗凝及支架置入后是否加用阿司匹林未达成共识。

核心结论

  • 该共识为优化静脉支架使用以预防深静脉血栓患者的血栓后综合征提供了实用见解,涉及支架选择、放置和术后护理等关键方面,有助于临床决策;所识别的分歧凸显了共识的重要性,并提示需进一步研究。

研究设计与样本

  • 德尔菲共识流程,2023年6月至7月由20名内科、血管外科及血管与介入放射学专家参与,对31条建议进行评估,共识定义为三分之二参与者同意,采用Likert量表评价一致性。

诊断标准与关键数值

  • 共识达成定义为三分之二参与者同意,31条建议中23条(74.2%)达成共识。
  • 在预防移位的推荐支架长度上存在分歧。
  • 在基于髂腔分叉形态的支架特性上存在分歧。
  • 对短暂性重大危险因素所致深静脉血栓患者是否需要超过3个月抗凝治疗未达成共识。
  • 对静脉支架置入后是否在抗凝治疗基础上加用阿司匹林未达成共识。

临床应用与阅片要点

  • 共识建议可为深静脉血栓患者优化静脉支架使用以预防血栓后综合征提供实践参考。
  • 支架选择、放置和术后护理是临床决策中的关键方面。
  • 对短暂性重大危险因素所致深静脉血栓的抗凝时长及支架后是否加用阿司匹林,专家未达成共识,原文未据此给出推荐。

局限性

  • 在预防移位的推荐支架长度上存在分歧。
  • 在基于髂腔分叉形态的支架特性上存在分歧。
  • 对短暂性重大危险因素所致深静脉血栓是否需要超过3个月抗凝治疗未达成共识。
  • 对静脉支架置入后是否加用阿司匹林未达成共识。
  • 所识别的分歧提示需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

INTRODUCTION: Deep vein thrombosis (DVT) poses a complex challenge and often leads to postthrombotic syndrome (PTS), a debilitating complication. The emergence of venous stents offers a potential preventive avenue against this complication. This study aimed to provide consensus recommendations on the use of venous stent for DVT.

MATERIALS AND METHODS: From June to July 2023, 20 internal medicine, angiology and vascular surgery, and vascular and interventional radiology experts were involved in the Delphi process. Thirty-one recommendations, categorized into three thematic areas, were rigorously evaluated: indications for stent use, stent selection and placement, and monitoring and prevention of complications. Agreement was evaluated using a Likert scale, with consensus defined as agreement by two-thirds of the participants.

RESULTS: Consensus was reached for 23 (74.2%) of 31 recommendations. The agreement was centered on considerations, such as stent placement in specific acute DVT scenarios, emphasizing pivotal stent characteristics. However, there were divergences in the recommended stent length to prevent migration and stent characteristics based on iliocaval bifurcation morphology. Notably, there was no consensus on whether patients with DVT caused by a major transient risk factor need more than 3 months of anticoagulation therapy or whether aspirin should be added to anticoagulant treatment after venous stenting.

CONCLUSIONS: These consensus recommendations offer practical insights into optimizing venous stent use to prevent PTS in DVT patients. Addressing the critical aspects of stent selection, placement, and postprocedural care, these recommendations contribute to clinical decision-making. The identified divergences underscore the importance of consensus and thus indicate the need for further investigation.

来源:Semin Thromb Hemost,查看原文。版权归原作者所有。

引用

  1. Trujillo-Santos J, Demelo-Rodríguez P, Bravo de Laguna-Taboada A, et al. Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis. Semin Thromb Hemost. 2024. PMID: 38733984. doi:10.1055/s-0044-1786755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。